Open AccessThe histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer
Author(s) -
Shelby M. Knoche,
Gabrielle L. Brumfield,
Benjamin T. Goetz,
Bailee H. Sliker,
Alaina C. Larson,
Madeline T. Olson,
Brittany J. Poelaert,
Audrey Bavari,
Ying Yan,
Jennifer D. Black,
Joyce C. Solheim
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0273518
Subject(s) - vorinostat , pancreatic cancer , gemcitabine , histone deacetylase inhibitor , cancer research , histone deacetylase , cancer , medicine , biology , pharmacology , histone , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom